.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Argus Health
Dow
AstraZeneca
Cerilliant
QuintilesIMS
Citi
Julphar
Covington

Generated: December 14, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Par Pharm Inc

« Back to Dashboard

Applicant Generic Name NDA Strength Dosage Form
Par Pharm Incdextroamphetamine saccharate;amphetamine aspartate monohydrate;dextroamphetamine sulfate;amphetamine sulfate20615910MGCAPSULE, EXTENDED RELEASE;ORAL
Par Pharm Incdextroamphetamine saccharate;amphetamine aspartate monohydrate;dextroamphetamine sulfate;amphetamine sulfate20615915MGCAPSULE, EXTENDED RELEASE;ORAL
Par Pharm Incdextromethorphan hydrobromide;quinidine sulfate20299320MG;10MGCAPSULE;ORAL
Par Pharm Inccolchicine2039760.6MGTABLET;ORAL
Par Pharm Incmilnacipran hydrochloride20506250MGTABLET;ORAL
Par Pharm Incdextroamphetamine saccharate;amphetamine aspartate monohydrate;dextroamphetamine sulfate;amphetamine sulfate20615930MGCAPSULE, EXTENDED RELEASE;ORAL
Par Pharm Incmilnacipran hydrochloride20506225MGTABLET;ORAL
Par Pharm Incvardenafil hydrochloride20478610MGTABLET, ORALLY DISINTEGRATING;ORAL
Par Pharm Incmilnacipran hydrochloride20506212.5MGTABLET;ORAL
Par Pharm Incdextroamphetamine saccharate;amphetamine aspartate monohydrate;dextroamphetamine sulfate;amphetamine sulfate20615920MGCAPSULE, EXTENDED RELEASE;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cerilliant
Covington
Chinese Patent Office
Dow
Medtronic
Queensland Health
US Department of Justice
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot